Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials for Bayer
Explore 192 clinical trials worldwide
Search
Showing 1-50 of 192 trials
Active filters:
Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting
Sponsor: Bayer
Clinical Trials (192)
NCT07215403
Prescriptive Infusion Algorithm (PIA)
PHASE2
Not yet recruiting
12 participants
Started: May 1, 2026 · Completed: Mar 1, 2028
1 condition
2 sponsors
0 locations
NCT06800248
Efficacy and Safety of Emodepside in Participants With Soil-transmitted Helminth Infections
PHASE3
Not yet recruiting
315 participants
Started: Jan 31, 2026 · Completed: Sep 30, 2026
3 conditions
4 sponsors
1 location
NCT07192952
A Study to Learn More About How Safe Finerenone is, When it is Taken for a Longer Time With Standard Treatment, in Children and Young Adults With Heart Failure and Left Ventricular Systolic Dysfunction
PHASE3
Not yet recruiting
117 participants
Started: Jan 5, 2026 · Completed: Dec 30, 2030
2 conditions
1 sponsor
131 locations
NCT07071961
Regorafenib (Reg) and Lorigerlimab (Lor), RELO Regimen, in Treatment of High-risk Patients With Colorectal Cancer With Radiographic Occult Molecular Residual Disease After End of Established Definitive Therapy [ReLOAD Trial]
PHASE2
Not yet recruiting
16 participants
Started: Jan 1, 2026 · Completed: May 1, 2029
3 conditions
3 sponsors
1 location
NCT05477953
An Observational Pregnancy Safety Study in Women Who Were Exposed to the Drug Nifurtimox During Pregnancy to Learn About the Risk of Pregnancy Complications and About the Mother's and Baby's Health
N/A
Not yet recruiting
50 participants
Started: Dec 31, 2025 · Completed: Jan 31, 2032
1 condition
1 sponsor
10 locations
NCT05900388
A Study to Observe the Pattern of Use and Safety of Rivaroxaban in Children Under 2 Years Old With Venous Thromboembolism (VTE)
N/A
Not yet recruiting
850 participants
Started: Dec 31, 2025 · Completed: Jun 30, 2029
2 conditions
2 sponsors
4 locations
NCT06904274
A Study to Learn How Well Mirena Works as Compared to Oral Progestin in Nonatypical Endometrial Hyperplasia in Women Who Have Started Their Periods
PHASE3
Not yet recruiting
300 participants
Started: Dec 1, 2025 · Completed: Jan 20, 2027
1 condition
1 sponsor
54 locations
NCT06902246
Regorafenib and Yttrium-90 Radioembolization for Unresectable Hepatocellular Carcinoma
PHASE2
Recruiting
30 participants
Started: Nov 1, 2025 · Completed: Nov 1, 2030
2 conditions
2 sponsors
1 location
NCT07088458
An Observational Study to Learn More About How Well Damoctocog Alfa Pegol Works in Previously Treated Children With Hemophilia A
N/A
Not yet recruiting
40 participants
Started: Nov 1, 2025 · Completed: Jan 1, 2030
1 condition
1 sponsor
0 locations
NCT06736691
Efficacy and Safety of Emodepside in Participants With Soil-transmitted Helminth Infections
PHASE3
Not yet recruiting
315 participants
Started: Oct 31, 2025 · Completed: Apr 30, 2026
3 conditions
4 sponsors
1 location
NCT07188805
A Study to Learn More About How Well Finerenone Works, How Safe it is, and How it Moves Into, Through, and Out of the Body Compared to Placebo When Taken With Standard Treatment in Children With Heart Failure and Left Ventricular Systolic Dysfunction
PHASE3
Not yet recruiting
111 participants
Started: Oct 30, 2025 · Completed: Dec 30, 2029
2 conditions
1 sponsor
132 locations
NCT07142551
Supraphysiologic Testosterone Priming Induces Darolutamide Extended Response
PHASE2
Not yet recruiting
60 participants
Started: Oct 30, 2025 · Completed: Jun 1, 2034
1 condition
2 sponsors
1 location
NCT06906640
Implementation pRogram to Improve Screening and Management for CKD in Diabetes (IRIS-CKD) (Program 2)
NA
Not yet recruiting
1,170 participants
Started: Oct 15, 2025 · Completed: Apr 1, 2027
3 conditions
4 sponsors
1 location
NCT06906627
Implementation pRogram to Improve Screening and Management for CKD in Diabetes (Program 1) (IRIS-CKD)
NA
Not yet recruiting
800 participants
Started: Oct 10, 2025 · Completed: Apr 1, 2027
3 conditions
4 sponsors
6 locations
NCT06632483
An Observational Study to Learn More About How Safe Vericiguat is and How Well it Works in Indian People With Chronic Heart Failure With Reduced Ejection Fraction and Worsening Chronic Heart Failure Under Real World Conditions
N/A
Not yet recruiting
1,200 participants
Started: Oct 1, 2025 · Completed: Apr 30, 2026
2 conditions
1 sponsor
1 location
NCT07211685
BAY3401016; Biomarker Study Alport
PHASE2
Not yet recruiting
60 participants
Started: Sep 30, 2025 · Completed: Jul 27, 2028
1 condition
1 sponsor
60 locations
NCT07155694
Role of Finerenone in African American Veterans With Diabetic Kidney Disease
PHASE4
Not yet recruiting
30 participants
Started: Sep 30, 2025 · Completed: Aug 31, 2027
1 condition
2 sponsors
1 location
NCT06763146
An Observational Study to Learn More About How Safe Finerenone is and How Well it Works in Indian People With Chronic Kidney Disease and Type 2 Diabetes in Routine Medical Practice
N/A
Active, not recruiting
1,200 participants
Started: Sep 23, 2025 · Completed: Jan 31, 2026
2 conditions
1 sponsor
1 location
NCT07176728
A Study to Assess the Safety and Effects of Different Doses of an Investigational Drug, BAY 3389934, in Healthy Japanese Volunteers.
PHASE1
Recruiting
16 participants
Started: Sep 22, 2025 · Completed: Jan 30, 2026
1 condition
1 sponsor
1 location
NCT06993246
Contrast-enhanced Mammography in Women With a Personal History of Breast Cancer and Dense Breast Tissue: Benefit?
NA
Not yet recruiting
50 participants
Started: Sep 15, 2025 · Completed: Sep 30, 2028
1 condition
2 sponsors
1 location
NCT07129239
High Dose (HD) Aflibercept Switch in Neovascular Age-related Macular Degeneration (nAMD): to Load or Maintain (HEIRLOOM)
PHASE3
Not yet recruiting
180 participants
Started: Aug 20, 2025 · Completed: Feb 28, 2027
1 condition
2 sponsors
1 location
NCT07142655
An Observational Study to Learn More About the Safety of Rivaroxaban in Participants With Peripheral Arterial Disease Who Had Surgery to Improve Blood Flow to Their Legs
N/A
Active, not recruiting
1,500 participants
Started: Aug 12, 2025 · Completed: Oct 31, 2025
1 condition
1 sponsor
1 location
NCT07102095
A Study Evaluating How Moderate Liver Impairment Affects the Absorption, Distribution, Metabolism, and Elimination of Sevabertinib After a Single Oral Dose
PHASE1
Recruiting
20 participants
Started: Jul 24, 2025 · Completed: Jan 23, 2026
4 conditions
1 sponsor
2 locations
NCT07124039
An Observational Study Called FIRST-2.0 China to Learn More About the Use of the Study Treatment Finerenone Including How Safe it is and How Well it Works Under Real-world Conditions in a Chinese Population.
N/A
Active, not recruiting
5,000 participants
Started: Jul 16, 2025 · Completed: Mar 30, 2026
2 conditions
1 sponsor
1 location
NCT07027124
Neoadjuvant ADT + Darolutamide With Pembrolizumab, Followed by Adjuvant Pembrolizumab in Molecularly Stratified High-Risk Prostate Cancer
PHASE2
Not yet recruiting
40 participants
Started: Jun 30, 2025 · Completed: May 2, 2031
2 conditions
3 sponsors
1 location
NCT07023341
A Study to Learn More About How Well Aficamten Works in Japanese Participants With Symptomatic Obstructive Hypertrophic Cardiomyopathy
PHASE3
Recruiting
34 participants
Started: Jun 30, 2025 · Completed: May 30, 2028
1 condition
1 sponsor
25 locations
NCT06944522
A Study to Investigate the Efficacy and Safety of Bemdaneprocel in Adults Who Have Parkinson's Disease
PHASE3
Recruiting
102 participants
Started: Jun 17, 2025 · Completed: Mar 31, 2032
1 condition
2 sponsors
10 locations
NCT07208422
Task-Specific Self-Rehabilitation Training (TASSRET) for Improving Functional Mobility in Community-Dwelling Stroke Survivors in a Low-Resource Setting
NA
Recruiting
50 participants
Started: Jun 7, 2025 · Completed: Nov 30, 2025
4 conditions
2 sponsors
1 location
NCT06949553
An Observational Study to Learn More About Vasomotor Symptoms Burden and Treatment Patterns in Menopausal Women Before and After Participating in OASIS Studies
N/A
Recruiting
250 participants
Started: Apr 30, 2025 · Completed: Feb 15, 2029
1 condition
1 sponsor
1 location
NCT06929143
A Study to Learn More About the Use of Aflibercept in Routine Medical Practice in Japanese Participants With Neovascular Age-related Macular Degeneration and Diabetic Macular Edema
N/A
Active, not recruiting
3,000 participants
Started: Apr 14, 2025 · Completed: Jul 31, 2026
2 conditions
1 sponsor
1 location
NCT06625970
Study Evaluating the Efficacy and Safety of Darolutamide and Stereotactic Dose Escalated Radiotherapy in Patients With Localized Prostate Cancer and High-risk Features of Relapse
PHASE3
Recruiting
700 participants
Started: Apr 10, 2025 · Completed: Oct 31, 2045
2 conditions
2 sponsors
6 locations
NCT06415227
The Impact of Vericiguat on Microvascular Function in Patients with Documented Vasospastic Angina Pectoris
PHASE2
Not yet recruiting
55 participants
Started: Apr 1, 2025 · Completed: Jun 1, 2026
1 condition
2 sponsors
0 locations
NCT06914128
A First-in-human Study to Learn How Safe BAY 3713372 is and How it Works in Participants With MTAP-deleted Solid Tumors
PHASE1/PHASE2
Recruiting
370 participants
Started: Mar 21, 2025 · Completed: Jun 17, 2029
1 condition
1 sponsor
37 locations
NCT06874114
An Observational Study to Learn More About Treatment Patterns and Factors Determining the Choice of Treatment in Canadian Men With Metastatic Hormone Sensitive Prostate Cancer in Routine Medical Care
N/A
Active, not recruiting
700 participants
Started: Feb 28, 2025 · Completed: Dec 31, 2026
1 condition
1 sponsor
1 location
NCT06764316
A First-in-human Study to Learn About the Safety of BAY 3547926 and How Well it Works in Participants With Advanced Liver Cancer
PHASE1
Recruiting
148 participants
Started: Feb 28, 2025 · Completed: Dec 31, 2033
1 condition
1 sponsor
10 locations
NCT06659926
The Radium-select Study
NA
Recruiting
60 participants
Started: Feb 24, 2025 · Completed: Jul 1, 2029
2 conditions
2 sponsors
5 locations
NCT06627530
COACTION Trial - COmbination Androgen bloCkade in inTermediate to hIgh-risk prOstate caNcer
PHASE4
Recruiting
144 participants
Started: Feb 17, 2025 · Completed: Sep 30, 2026
1 condition
2 sponsors
6 locations
NCT06760819
A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
PHASE2
Recruiting
111 participants
Started: Feb 13, 2025 · Completed: Oct 25, 2027
2 conditions
1 sponsor
54 locations
NCT06772025
A Study to Understand How Cardiac Surgery-associated Acute Kidney Injury Develops in Participants Who Undergo Heart Surgery With the Use of Heart-lung Machine
NA
Recruiting
200 participants
Started: Feb 3, 2025 · Completed: Dec 6, 2026
1 condition
1 sponsor
4 locations
NCT06986798
A Study to Learn About the Occurrence of Disseminated Intravascular Coagulation in People With Sepsis and Further Worsening of Sepsis
NA
Recruiting
150 participants
Started: Jan 29, 2025 · Completed: Apr 7, 2026
2 conditions
1 sponsor
32 locations
NCT06765681
An Observational Study in the United States to Learn How Venous Thromboembolism, Disseminated Intravascular Coagulation, and Sepsis Are Related
N/A
Active, not recruiting
10,000 participants
Started: Jan 6, 2025 · Completed: Sep 30, 2025
3 conditions
1 sponsor
1 location
NCT06463457
Comeback From Long coursE Androgen Deprivation Therapy (ADT) With RElugolix and Darolutamide (CLEARED)
PHASE2
Active, not recruiting
33 participants
Started: Dec 13, 2024 · Completed: Nov 30, 2028
3 conditions
5 sponsors
3 locations
NCT06728332
An Observational Study to Learn More About How Menopause Affects Women's Sleep and How They Are Being Treated for Sleep Problems
N/A
Recruiting
1,000 participants
Started: Dec 6, 2024 · Completed: Oct 14, 2025
1 condition
1 sponsor
1 location
NCT06661122
A Study to Learn About How Safe Darolutamide is and How Well it Works in Combination With Androgen Deprivation Therapy and Docetaxel in Routine Medical Care for Japanese Men With Low Volume Metastatic Hormone-Sensitive Prostate Cancer
N/A
Recruiting
100 participants
Started: Nov 18, 2024 · Completed: Aug 31, 2031
2 conditions
1 sponsor
1 location
NCT06659341
A Phase I Study of BAY3498264 Given Together With Sotorasib in Participants Who Have Advanced Solid Cancers With Specific Genetic Changes Called KRASG12C Mutation
PHASE1
Recruiting
104 participants
Started: Nov 8, 2024 · Completed: Mar 7, 2028
1 condition
1 sponsor
10 locations
NCT06631521
Neoadjuvant Darolutamide and Relugolix Combination Preceding Radical Prostatectomy for Prostate Cancer
PHASE1
Recruiting
30 participants
Started: Oct 22, 2024 · Completed: Jun 30, 2026
3 conditions
3 sponsors
1 location
NCT06608212
An Observational Study to Learn More About How Safe Finerenone is and How Well it Works in People With Chronic Kidney Disease and Type 2 Diabetes in Routine Medical Care in the United States
N/A
Active, not recruiting
150,000 participants
Started: Oct 9, 2024 · Completed: Dec 31, 2025
2 conditions
1 sponsor
1 location
NCT06276465
Treatment With Darolutamide +/- Radiation Therapy for Patients With a Castration Resistant Cancer and Metastases Detected by Functional Imaging
PHASE3
Recruiting
336 participants
Started: Oct 7, 2024 · Completed: Oct 7, 2032
1 condition
2 sponsors
4 locations
NCT06334120
An Observational Study to Learn More About the Safety of Darolutamide in Men With Prostate Cancer in Korea
N/A
Recruiting
600 participants
Started: Sep 25, 2024 · Completed: Jun 30, 2026
2 conditions
1 sponsor
1 location
NCT06275919
Regorafenib for Recurrent Grade 2 and 3 Meningioma (MIRAGE Trial)
PHASE2
Recruiting
104 participants
Started: Sep 23, 2024 · Completed: Mar 31, 2027
1 condition
2 sponsors
16 locations
«
Previous
1
2
3
4
Next